Total Payments
$473.97
2024 Payments
$105.93
Companies
6
Transactions
11
Medicare Patients
2,769
Medicare Billing
$757,721
Payment Breakdown by Category
Food & Beverage$458.58 (96.8%)
Education$15.39 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $458.58 | 9 | 96.8% |
| Education | $15.39 | 2 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $250.57 | 2 | $0 (2023) |
| Ethicon Inc. | $105.93 | 1 | $0 (2024) |
| Boston Scientific Corporation | $40.76 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $32.92 | 2 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $31.09 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $12.70 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.93 | 1 | Ethicon Inc. ($105.93) |
| 2023 | $283.49 | 4 | ABBVIE INC. ($250.57) |
| 2022 | $40.76 | 1 | Boston Scientific Corporation ($40.76) |
| 2019 | $12.70 | 1 | Merck Sharp & Dohme Corporation ($12.70) |
| 2017 | $31.09 | 4 | Sunovion Pharmaceuticals Inc. ($31.09) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $105.93 | General |
| Category: Endo-Mechanical | ||||||
| 08/31/2023 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/14/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Respiratory | ||||||
| 06/19/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Respiratory | ||||||
| 06/08/2023 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $125.58 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/08/2022 | Boston Scientific Corporation | General - Thrombectomy (Device) | Food and Beverage | In-kind items and services | $40.76 | General |
| Category: General - Thrombectomy_PI | ||||||
| 11/04/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/30/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: RESPIRATORY | ||||||
| 08/11/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: RESPIRATORY | ||||||
| 08/11/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 581 | 1,274 | $280,094 | $138,181 |
| 2022 | 9 | 562 | 1,336 | $356,830 | $165,804 |
| 2021 | 5 | 690 | 2,377 | $457,776 | $225,213 |
| 2020 | 5 | 936 | 2,353 | $465,325 | $228,523 |
Total Patients
2,769
Total Services
7,340
Medicare Billing
$757,721
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 126 | 384 | $144,384 | $61,145 | 42.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 157 | 450 | $67,500 | $40,565 | 60.1% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 30 | 105 | $19,950 | $12,294 | 61.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 83 | 94 | $12,220 | $5,572 | 45.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 49 | 49 | $10,780 | $4,618 | 42.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 23 | 48 | $6,240 | $3,909 | 62.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 39 | $5,850 | $3,537 | 60.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 48 | $5,280 | $3,038 | 57.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $3,600 | $2,032 | 56.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 12 | 13 | $1,300 | $556.53 | 42.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 12 | 13 | $1,300 | $534.04 | 41.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 12 | 13 | $1,690 | $379.86 | 22.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 175 | 635 | $238,760 | $108,412 | 45.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 183 | 461 | $69,150 | $37,997 | 54.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 75 | 79 | $17,380 | $8,267 | 47.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 71 | 86 | $11,180 | $4,399 | 39.3% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 13 | 27 | $5,130 | $2,791 | 54.4% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 11 | 12 | $3,600 | $1,319 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $1,430 | $920.40 | 64.4% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2022 | 11 | 11 | $6,600 | $914.64 | 13.9% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 11 | 12 | $3,600 | $784.65 | 21.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 158 | 523 | $186,586 | $95,539 | 51.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 298 | 1,555 | $209,360 | $93,055 | 44.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 108 | 117 | $31,620 | $19,441 | 61.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 65 | 116 | $17,400 | $9,879 | 56.8% |
About Dr. Jacinto Kadour Rodriguez, MD
Dr. Jacinto Kadour Rodriguez, MD is a Internal Medicine healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1649480534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacinto Kadour Rodriguez, MD has received a total of $473.97 in payments from pharmaceutical and medical device companies, with $105.93 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($458.58).
As a Medicare-enrolled provider, Kadour Rodriguez has provided services to 2,769 Medicare beneficiaries, totaling 7,340 services with total Medicare billing of $757,721. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Weslaco, TX
- Active Since 05/22/2007
- Last Updated 02/17/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649480534
Products in Payments
- TEFLARO (Drug) $250.57
- Monarch Platform (Device) $105.93
- General - Thrombectomy (Device) $40.76
- TEZSPIRE (Biological) $32.92
- UTIBRON (Drug) $31.09
- ZERBAXA (Drug) $12.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Weslaco
Hector Amaya Chinchilla, M.d, M.D
Internal Medicine — Payments: $5,736
Internal Medicine $5,736
Dionisio Calvo
Internal Medicine — Payments: $4,184
Internal Medicine $4,184
Dr. Claudia Pierson, M.d, M.D
Internal Medicine — Payments: $3,969
Internal Medicine $3,969
Pedro Penalo, Md, MD
Internal Medicine — Payments: $3,559
Internal Medicine $3,559
Dr. Robert Sepulveda, M.d, M.D
Internal Medicine — Payments: $2,673
Internal Medicine $2,673
Jesus Rodriguez Hernandez, M.d, M.D
Internal Medicine — Payments: $2,593
Internal Medicine $2,593